OPSEU Pension Plan Trust Fund’s Alnylam Pharmaceuticals ALNY Stock Holding History

OPSEU Pension Plan Trust Fund’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,610	Closed	-$659K	–	267
2021 Q1	$659K	Buy	4,610 +94	+2%	+$14.1K	0.17%	218
2020 Q4	$582K	Buy	4,516 +30	+0.7%	+$4.01K	0.17%	224
2020 Q3	$663K	Sell	4,486 -347	-7%	-$49.3K	0.21%	205
2020 Q2	$715K	Buy	+4,833	New	+$652K	0.24%	180

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OPSEU Pension Plan Trust Fund's ALNY Position: Q2 2021 in Review

OPSEU Pension Plan Trust Fund sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2021, closing a stake of 4,610 shares — an estimated $659K sold.

OPSEU Pension Plan Trust Fund first reported a position in ALNY in Q2 2020 and held it in 4 quarters. The position peaked at $715K in Q2 2020. 401 funds tracked by Wall St. Rank hold ALNY as of Q2 2021.

OPSEU Pension Plan Trust Fund reported no remaining Alnylam Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
OPSEU Pension Plan Trust Fund sold 4,610 Alnylam Pharmaceuticals shares in Q2 2021, an estimated $659K.
OPSEU Pension Plan Trust Fund first reported a position in Alnylam Pharmaceuticals in Q2 2020 and held it in 4 quarters.
OPSEU Pension Plan Trust Fund's Alnylam Pharmaceuticals position peaked at $715K in Q2 2020.
401 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2021.

Based on OPSEU Pension Plan Trust Fund's 13F filing for Q2 2021, filed 11 Aug 2021.